Cargando…

Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism

Diabetic cardiomyopathy (DCM) is one of the many complications of diabetes. DCM leads to cardiac insufficiency and myocardial remodeling and is the main cause of death in diabetic patients. Abnormal lipid metabolism plays an important role in the occurrence and development of DCM. Huangqi Shengmai Y...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Zhanhong, Pan, Jianheng, Sui, Xin, Fang, Chunqiu, Li, Na, Huang, Xiaowei, Qu, Xiaobo, Han, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238573/
https://www.ncbi.nlm.nih.gov/pubmed/34249132
http://dx.doi.org/10.1155/2021/5590623
_version_ 1783714926430257152
author Cao, Zhanhong
Pan, Jianheng
Sui, Xin
Fang, Chunqiu
Li, Na
Huang, Xiaowei
Qu, Xiaobo
Han, Dong
author_facet Cao, Zhanhong
Pan, Jianheng
Sui, Xin
Fang, Chunqiu
Li, Na
Huang, Xiaowei
Qu, Xiaobo
Han, Dong
author_sort Cao, Zhanhong
collection PubMed
description Diabetic cardiomyopathy (DCM) is one of the many complications of diabetes. DCM leads to cardiac insufficiency and myocardial remodeling and is the main cause of death in diabetic patients. Abnormal lipid metabolism plays an important role in the occurrence and development of DCM. Huangqi Shengmai Yin (HSY) has previously been shown to alleviate signs of heart disease. Here, we investigated whether HSY could improve cardiomyopathy caused by type 1 diabetes mellitus (T1DM) and improve abnormal lipid metabolism in the diabetic heart. Streptozotocin (STZ) was used to establish the T1DM mouse model, and T1DM mice were subsequently treated with HSY for eight weeks. The changes in the cardiac conduction system, histopathology, blood myocardial injury indices, and lipid content and expression of proteins related to lipid metabolism were evaluated. Our results showed that HSY could improve electrocardiogram; decrease the serum levels of CK-MB, LDH, and BNP; alleviate histopathological changes in cardiac tissue; and decrease myocardial lipid content in T1DM mice. These results indicate that HSY has a protective effect against T1DM-induced myocardial injury in mice and that this effect may be related to the improvement in myocardial lipid metabolism.
format Online
Article
Text
id pubmed-8238573
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-82385732021-07-08 Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism Cao, Zhanhong Pan, Jianheng Sui, Xin Fang, Chunqiu Li, Na Huang, Xiaowei Qu, Xiaobo Han, Dong Evid Based Complement Alternat Med Research Article Diabetic cardiomyopathy (DCM) is one of the many complications of diabetes. DCM leads to cardiac insufficiency and myocardial remodeling and is the main cause of death in diabetic patients. Abnormal lipid metabolism plays an important role in the occurrence and development of DCM. Huangqi Shengmai Yin (HSY) has previously been shown to alleviate signs of heart disease. Here, we investigated whether HSY could improve cardiomyopathy caused by type 1 diabetes mellitus (T1DM) and improve abnormal lipid metabolism in the diabetic heart. Streptozotocin (STZ) was used to establish the T1DM mouse model, and T1DM mice were subsequently treated with HSY for eight weeks. The changes in the cardiac conduction system, histopathology, blood myocardial injury indices, and lipid content and expression of proteins related to lipid metabolism were evaluated. Our results showed that HSY could improve electrocardiogram; decrease the serum levels of CK-MB, LDH, and BNP; alleviate histopathological changes in cardiac tissue; and decrease myocardial lipid content in T1DM mice. These results indicate that HSY has a protective effect against T1DM-induced myocardial injury in mice and that this effect may be related to the improvement in myocardial lipid metabolism. Hindawi 2021-06-18 /pmc/articles/PMC8238573/ /pubmed/34249132 http://dx.doi.org/10.1155/2021/5590623 Text en Copyright © 2021 Zhanhong Cao et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Cao, Zhanhong
Pan, Jianheng
Sui, Xin
Fang, Chunqiu
Li, Na
Huang, Xiaowei
Qu, Xiaobo
Han, Dong
Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism
title Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism
title_full Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism
title_fullStr Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism
title_full_unstemmed Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism
title_short Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism
title_sort protective effects of huangqi shengmai yin on type 1 diabetes-induced cardiomyopathy by improving myocardial lipid metabolism
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238573/
https://www.ncbi.nlm.nih.gov/pubmed/34249132
http://dx.doi.org/10.1155/2021/5590623
work_keys_str_mv AT caozhanhong protectiveeffectsofhuangqishengmaiyinontype1diabetesinducedcardiomyopathybyimprovingmyocardiallipidmetabolism
AT panjianheng protectiveeffectsofhuangqishengmaiyinontype1diabetesinducedcardiomyopathybyimprovingmyocardiallipidmetabolism
AT suixin protectiveeffectsofhuangqishengmaiyinontype1diabetesinducedcardiomyopathybyimprovingmyocardiallipidmetabolism
AT fangchunqiu protectiveeffectsofhuangqishengmaiyinontype1diabetesinducedcardiomyopathybyimprovingmyocardiallipidmetabolism
AT lina protectiveeffectsofhuangqishengmaiyinontype1diabetesinducedcardiomyopathybyimprovingmyocardiallipidmetabolism
AT huangxiaowei protectiveeffectsofhuangqishengmaiyinontype1diabetesinducedcardiomyopathybyimprovingmyocardiallipidmetabolism
AT quxiaobo protectiveeffectsofhuangqishengmaiyinontype1diabetesinducedcardiomyopathybyimprovingmyocardiallipidmetabolism
AT handong protectiveeffectsofhuangqishengmaiyinontype1diabetesinducedcardiomyopathybyimprovingmyocardiallipidmetabolism